Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Eur Urol. 2013 Apr 3;64(4):672–679. doi: 10.1016/j.eururo.2013.03.041

Table 1.

Distribution of baseline characteristics among men who did not and did report a history of prostate cancer in the Osteoporotic Fractures in Men study

PCa
Yes No
No. (%) 706 (12) 5284 (88)

Baseline characteristic p value
Age, no. (%)
 65–69 yr 131 (18.6) 1638 (31.0) <0.0001
 70–79 yr 377 (53.4) 2777 (52.6)
 ≥80 yr 198 (28.0) 869 (16.5)
Caucasian race, no. (%) 625 (88.5) 4733 (89.6) 0.40
BMI, kg/m2, mean (SD) 27.4 (3.8) 27.4 (3.8) 0.76
Alcohol consumption, drinks per week, median (IQR) 1.0 (0.0–7.0) 1.0 (0.0–7.0) 0.69
 No 280 (39.7) 1967 (37.2) 0.03
 Past 413 (58.5) 3124 (59.1)
 Current 13 (1.8) 192 (3.6)
Self-reported health fair or poor, no. (%) 125 (17.7) 732 (13.9) 0.006
Previous BPH diagnosis, no. (%) 389 (55.1) 2539 (48.1) 0.0004
Medical history, no. (%)
 Any heart disease 159 (22.5) 1269 (24.0) 0.38
 Self-reported diabetes 67 (9.5) 586 (11.1) 0.20
 Self-reported hypertension 304 (43.1) 2276 (43.1) 0.99
 Self-reported cancer, not PCa 216 (30.6) 1036 (19.6) <0.0001
Years since PCa diagnosis, mean (SD) 6.3 (4.8)
PCa major treatment, no. (%)
 Surgery 362 (51.3)
 Radiation therapy 204 (29.0)
 Hormones 68 (9.6)
 Observation 42 (6.0)
 Other treatment 30 (4.3)

PCa = prostate cancer; BMI = body mass index; SD = standard deviation; IQR = interquartile range; BPH = benign prostatic hyperplasia.